{
    "title": "AstraZeneca receives a boost after two liver cancer treatments get the green light",
    "url": "https://www.dailymail.co.uk/money/markets/article-11349969/AstraZeneca-receives-boost-two-liver-cancer-treatments-green-light.html",
    "date": "2022-10-24",
    "keywords": [
        "cancer",
        "drug",
        "liver",
        "cent",
        "share",
        "boost",
        "pipeline",
        "fund",
        "use",
        "trial",
        "risk",
        "imfinzi",
        "business",
        "capital",
        "investment",
        "account",
        "fee",
        "food",
        "administration",
        "fda",
        "light",
        "ftse",
        "carcinoma",
        "type",
        "world",
        "uk",
        "year",
        "research",
        "cancerthe",
        "decision",
        "combination",
        "drop",
        "death",
        "medicine",
        "thyroid",
        "imjudo",
        "auto",
        "trader",
        "group",
        "cerillion",
        "software",
        "demand",
        "language",
        "britain",
        "recession",
        "activity",
        "stake",
        "mike",
        "party",
        "article",
        "contain",
        "bodys",
        "immune",
        "system",
        "broker",
        "shore",
        "approval",
        "scope",
        "news",
        "string",
        "astrazeneca",
        "covid",
        "jab",
        "price",
        "secondmost",
        "firm",
        "london",
        "stock",
        "exchange",
        "oil",
        "giant",
        "shell",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}